Parkinson's Disease Trial, Recruiting NCT05864157 Sponsor: University of North Carolina, Chapel Hill Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05864157
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's with no known cause) at a moderate stage of the condition
  • People who are able to walk for 10 minutes in a row, both on a regular surface and on a treadmill, without help from a therapist
  • People whose walking speed falls within a specific moderate range (not too slow and not too fast)
  • People with normal hearing, or hearing that is corrected to normal with a hearing aid
  • People who show noticeable walking difficulties, such as shuffling, short steps, freezing, or slowness of movement, as observed by a specialist
  • People whose Parkinson's-related movement symptoms fall within a specific score range on a standard medical rating scale (confirm with trial site)
  • People who are on a stable, regular oral dose of a medication called levodopa
  • People aged between 50 and 80 years old

Who may not be able to join:

  • People who cannot safely have an MRI scan, for example due to metal implants in the body or severe claustrophobia
  • People who score below a certain level on a standard memory and thinking assessment
  • People who are currently receiving physiotherapy treatment
  • People who have had deep brain stimulation surgery
  • People who are unable to walk without physical assistance from a therapist
  • People who have an uncontrolled heart or lung condition, a metabolic disease, another neurological condition, or a bone or joint injury that affects the way they walk

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mike Lewek, PT, PhD, Associate Professor

Phone: 919-966-4041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 August 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Six minute walk test (6MWT) at the 3 month follow up visit

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov